Prognostic role of serum cancer antigen 15-3 in breast cancer patients with isolated bone metastases

By Turanli Sevim   Cetin Abdullah  

Biomarkers, Vol. 15, Iss. 5, 2010-08 ,pp. : 418-423

Informa Healthcare

Access to resources Recommend Favorite

Denosumab as a promising novel bone-targeted agent in castration resistant prostate cancer

By Dellis Athanasios   Papatsoris Athanasios G  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 7-10

Informa Healthcare

Access to resources Recommend Favorite

Differential Expression of Alternatively Spliced c-erbB-2 mRNA in Primary Tumors, Lymph Node Metastases, and Bone Marrow Micrometastases from Breast Cancer Patients

By Gebhardt F.   Zanker K.S.   Brandt B.  

Biochemical and Biophysical Research Communications, Vol. 247, Iss. 2, 1998-06 ,pp. : 319-323

Elsevier

Access to resources Recommend Favorite

Denosumab – an emerging treatment for postmenopausal osteoporosis

By Lewiecki E Michael  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 467-476

Informa Healthcare

Access to resources Recommend Favorite

Structure-Based Design of Specific Cathepsin Inhibitors and Their Application to Protection of Bone Metastases of Cancer Cells

By Katunuma N.   Tsuge H.   Nukatsuka M.   Asao T.   Fukushima M.  

Archives of Biochemistry and Biophysics, Vol. 397, Iss. 2, 2002-01 ,pp. : 305-311

Elsevier

Access to resources Recommend Favorite